ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,877Medicare Part D Prescriptions Filled, Including Refills

Rank: 296 out of 2343

$625K Total Retail Price of All Prescriptions

Rank: 431 out of 2343

442 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

46% of this provider’s 442 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 442 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 6,034 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
ENDOCET 935 264 S2 10 1 97
OMEPRAZOLE 583 326 2 4
AMLODIPINE BESYLATE 470 300 3 5
LISINOPRIL 427 301 4 3
GABAPENTIN 378 145 5 16
OXYCODONE HCL 281 48 S2 6 67
METFORMIN HCL 278 132 7 9
VENTOLIN HFA 271 62 8 79
METOPROLOL TARTRATE 250 132 9 7
IBUPROFEN 248 125 10 75
FUROSEMIDE 245 181 11 6
FLUTICASONE PROPIONATE 240 35 12 46
HYDROCHLOROTHIAZIDE 236 70 13 11
HYDROCODONE-ACETAMINOPHEN 213 104 S3 14 13
CARISOPRODOL 206 12 R 15 176
LOVASTATIN 203 121 16 47
LEVOCETIRIZINE DIHYDROCHLORIDE 198 95 17 223
AZITHROMYCIN 172 53 18 39
SIMVASTATIN 169 115 19 1
MORPHINE SULFATE ER 163 22 S2 20 142
WARFARIN SODIUM 153 124 21 8
TAMSULOSIN HCL 150 116 22 29
ZOLPIDEM TARTRATE 147 53 23 24
ADVAIR DISKUS 147 41 23 34
AMITRIPTYLINE HCL 141 37 R 25 117
LISINOPRIL-HYDROCHLOROTHIAZIDE 122 90 26 42
NIFEDIPINE ER 120 81 27 89
OXYCONTIN 120 26 S2 27 138
HYDROCORTISONE 114 46 29 225
RANITIDINE HCL 109 58 30 43
OXYCODONE HCL-ACETAMINOPHEN 106 22 S2 31 136
CARVEDILOL 106 73 31 27
SERTRALINE HCL 102 43 33 20
PROAIR HFA 100 0 34 86
DIOVAN 95 70 35 23
METOPROLOL SUCCINATE 92 74 36 14
TRAMADOL HCL 89 64 37 25
OXYCODONE-ACETAMINOPHEN 88 40 S2 38 49
AMLODIPINE BESYLATE-BENAZEPRIL 86 31 39 59
CYCLOBENZAPRINE HCL 85 19 R 40 109
CLOTRIMAZOLE-BETAMETHASONE 84 31 41 127
MIRTAZAPINE 80 67 42 41
GLIPIZIDE ER 80 49 42 115
NAPROXEN 73 68 44 108
POTASSIUM CHLORIDE 72 27 45 18
CITALOPRAM HBR 71 25 46 17
CLONIDINE HCL 70 21 47 70
GLIPIZIDE 69 42 48 56
QUETIAPINE FUMARATE 66 37 49 77
DILTIAZEM 24HR ER 63 47 50 76
PROMETHAZINE HCL 61 0 R 51 222
DIOVAN HCT 60 17 52 63
SPIRONOLACTONE 59 33 53 65
ALLOPURINOL 58 31 54 31
SPIRIVA 57 41 55 48
ATORVASTATIN CALCIUM 56 34 56 10
LEVOTHYROXINE SODIUM 55 43 57 2
ATENOLOL 54 44 58 12
CLOPIDOGREL 54 35 58 26
AMMONIUM LACTATE 52 29 60 228
PLAVIX 51 27 61 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.